Invention Grant
- Patent Title: Gene expression markers and treatment of multiple sclerosis
-
Application No.: US15662079Application Date: 2017-07-27
-
Publication No.: US11236391B2Publication Date: 2022-02-01
- Inventor: Michael Townsend , Alvernia Francesca Setiadi , Tracy Staton
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Baker Botts L.L.P.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; C07K16/28 ; C12Q1/6883 ; G01N33/564 ; A61K39/00
Abstract:
The present invention concerns markers of multiple sclerosis, their use, and treatment with IL-17 antagonists, including IL-17 antibodies, of subjects with increased levels of such markers.
Public/Granted literature
- US20180080080A1 GENE EXPRESSION MARKERS AND TREATMENT OF MULTIPLE SCLEROSIS Public/Granted day:2018-03-22
Information query
